Stock Watcher's Thread / Pix of the Week (POW) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stock Watcher's Thread / Pix of the Week (POW)

VEEV 240.09

-0.1%

Dec 2 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mac who wrote (1584)	1/31/1999 3:35:00 PM
From: Stock Watcher	Read Replies (1) of 52051

Mac; SCLN & CELN; first CELN; last 1.15 +.56 on 5M shares (wow!); they received the "ok" on their "Investigational Device Application"; they still have a long way to go...their press release at first glance could give one the impression that their procedure itself has been approved by the FDA(which is the farthest thing from the truth). It only means that CELN can experiment in certain controlled situations and begin approx. $15M worth of tests and expenditures. I think alot of investors thought CELN had received FDA approval for general usage. In addition: revenues fell 6% to 110K; loss rose 84% to 3.5M; 8 employees. SCLN; range .87 - 5.13; last: 2.19 + .63/revenues rose 25% to 2.5M/ loss rose 51% to 14.7M/float: 14.7M/35 employees. Big risk biotech stocks can = big gains/or no gains...regards, sw

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next